Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 158 clinical trials
Featured trial
A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Visual Impairment Due to Treatment-naïve Macular Edema Secondary to Retinal Vein Occlusion (RVO)

This Phase 3 study will evaluate the efficacy, durability, and safety of KSI-301 compared to aflibercept, in participants with macular edema due to treatment-naïve branch (BRVO) or central retinal

retinal vein occlusion
aflibercept
spectral domain optical coherence tomography
macular edema
  • 0 views
  • 24 Jun, 2021
  • 1 location
Featured trial
  • 2 views
  • 24 Jun, 2021
  • 1 location
Featured trial
A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects with Macular Edema associated with Non-Infectious Uveitis

A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects with Macular Edema

  • 192 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

  • 83 views
  • 25 Mar, 2021
  • 1 location
None
Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

To evaluate the safety and efficacy of LKA651 in patients with macular edema from diabetic macular edema (DME),

type 2 diabetes mellitus
lucentis
diabetes
spectral domain optical coherence tomography
  • 130 views
  • 05 Dec, 2021
  • 25 locations
None
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema

Efficacy duration of triamcinolone acetonide (steroid) for treatment of diabetic macular edema. Furthermore, dosage dependency of triamcinolone acetonide comparing a high dosage versus a

diabetic macular edema
edema
triamcinolone
macular edema
  • 33 views
  • 07 Nov, 2020
  • 1 location
None
Micropulse for Suppression of Diabetic Macular Edema

Diabetic retinopathy is one of the most common complications of diabetes and diabetic macular edema (DME) is one of the most common causes of vision loss in diabetes. The purpose of this

diabetes
type 2 diabetes mellitus
retinopathy
blindness
diabetic retinopathy
  • 30 views
  • 01 May, 2021
  • 1 location
None
Evaluation of RC28-E Injection in Diabetic Macular Edema

This is a non-randomized, open-label, multicenter, 48-week study to investigate the efficacy, safety and pharmacokinetics of RC28-E injection in the treatment of patients with diabetic macular

  • 3 views
  • 02 May, 2021
  • 1 location
None
Bevacizumab and Retinal Vascular Occlusions

To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.

angiography
fluorescein angiography
bevacizumab
  • 13 views
  • 07 Nov, 2020
  • 1 location
None
Intravitreal Bevacizumab for Retinal Disorders

Injection of bevacizumab (Avastin) for CNVM, Macular oedema due to diabetic retinopathy, vascular occlusion and other retinal disorders.

diabetic macular edema
macugen
retinopathy
diabetic retinopathy
macular degeneration
  • 23 views
  • 07 Nov, 2020
  • 1 location